Melanie Groleau

This profile gathers the share dealings of Melanie Groleau in Knight Therapeutics Inc. In total, 18 filings cover trades dated 10 June 2026.

The open-market record consists of 6 sales worth €280k, with no purchase. Besides market trades, the filings include 12 option exercises.

On 10 June 2026 came the latest disclosure, an open-market sale for €169k in Knight Therapeutics Inc. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.